Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CAStem intra-articular injection for meniscus injury
ChiCTR2200057251Phase 2Not yet recruiting
- Sponsor
- Peking University People's Hospital
- Start
- Feb 2022
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2 trial of CAStem cells in meniscal tear (2 arms), sponsored by Peking University People's Hospital. Primary endpoint: Safety. Planned start Feb 2022; status: not yet recruiting.
02
Drugs
CAStem cells
03
Conditions
meniscal tear
Beyond the preview
Go deeper on ChiCTR2200057251.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200057251.